• 1
    Birkeland SA,Storm HH,Lamm LU,Barlow L,Blohmé I,Forsberg B,Eklund B,Fjeldborg O,Friedberg M,Frödin L,Glattre E,Halvorsen S, et al. Cancer risk after renal transplantation in the nordic countries, 1964–1986. Int J Cancer 1995; 60: 1839.
  • 2
    Adami J,Gäbel H,Lindelöf B,Rydh B,Glimelius B,Ekbom A,Adami HO,Granath F. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 12217.
  • 3
    International Agency for Research on Cancer.Monographs on the evaluation of carcinogenic risks to humans, vol. 55. Lyon: IARC, 1992. 228 p.
  • 4
    International Agency for Research on Cancer.Monographs on the evaluation of carcinogenic risks to humans, vol. 90. Lyon: IARC, 2007, 476 p.
  • 5
    Antonsson A,Forslund O,Ekberg H,Sterner G,Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 1163641.
  • 6
    de Koning MNC,Struijk L,Bouwes Bavinck J-N,Kleter B,Ter Schegget J,Quint WGV,Feltkamp MCW. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88: 148995.
  • 7
    Harwood CA,Surentheran T,McGregor JM,Spink PJ,Leigh IM,Breuer J,Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 28997.
  • 8
    Forslund O,Lindelöf B,Hradil E,Nordin P,Stenquist B,Kirnbauer R,Slupetzky K,Dillner J. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in “stripped” biopsies from the same tumors. J Invest Dermatol 2004; 123: 38894.
  • 9
    Casabonne D,Michael KM,Waterboer T,Pawlita M,Forslund O,Burk RD,Travis RC,Key TJ,Newton R. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 18628.
  • 10
    Steger G,Olszewsky M,Stockfleth E Pfister HJ. Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol 1990; 64: 4399406.
  • 11
    Stark S,Petridis AK,Ghim S-J,Jenson AB,Bouwes Bavinck JN,Gross G,Stockfleth E,Fuchs PG,Pfister HJ. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998; 111: 696701.
  • 12
    Bouwes Bavinck JN,Stark S,Petridis AK,Marugg ME,Ter Schegget J,Westendorp RG,Fuchs PG,Vermeer BJ,Pfister HJ. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000; 142: 1039.
  • 13
    Favre M,Majewski S,Noszczyk B,Maienfisch F,Pura A,Orth G,Jablonska S. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000; 114: 4037.
  • 14
    Feltkamp MCW,Broer R,di Summa FM,Struijk L,Van der Meijden E,Verlaan BPJ,Westendorp RGJ,Ter Schegget J,Spaan WJM,Bouwes Bavinck JN. Seroactivity to epidermodysplasia verriciformis-related human papillomavirus type is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695700.
  • 15
    Masini C,Fuchs PG,Gabrielli F,Stark S,Sera F,Ploner M,Melchi CM,Primavera G,Pirchio G,Picconi O,Petasecca P,Cattaruzza MS, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003; 139: 8904.
  • 16
    Karagas RK,Nelson HH,Sehr P,Waterboer T,Stukel TA,Andrew A,Green A,Bouwes Bavinck JN,Perry A,Spencer S,Rees JR,Mott LA, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinoma of the skin. J NCI 2006; 98: 38995.
  • 17
    Struijk L,Hall L,Van der Meijden E,Wanningen P,Bouwes Bavinck JN,Neale R,Green AC,ter Schegget J,Feltkamp MCW. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidmiol Biomarkers Prev 2006; 15: 52935.
  • 18
    Andersson K,Waterboer T,Kirnbauer R,Slupetzky K,Iftner T,de Villiers E-M,Forslund O,Pawlita M,Dillner J. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008; 17: 18995.
  • 19
    Waterboer T,Abeni D,Sampogna F,Rother A,Masini C,Sehr P,Michael KM,Pawlita M. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 2008; 159: 45759.
  • 20
    Sehr P,Zumbach K,Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001; 253: 15362.
  • 21
    Sehr P,Müller M,Höpfl R,Widschwendter A,Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002; 106: 6170.
  • 22
    Waterboer T,Sehr P,Michael KM,Franceschi S,Nieland JD,Joos TO,Templin MF,Pawlita M. Multiplex human papillomavirus serology based on in situ purified glutathione S-transferase fusion proteins. Clin Chem 2005; 51: 184553.
  • 23
    Waterboer T,Sehr P,Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006; 309: 2004.
  • 24
    Michael KM,Waterboer T,Sehr P,Rother A,Reidel U,Boeing H,Bravo IG,Schlehofer J,Gärtner BC,Pawlita M. Seroprevalence of 34 human papillomavirus types in the german general population. PLoS Pathog 2008; 4: e1000091.
  • 25
    Harwood CA,Proby CM,McGregor JM,Sheaff MT,Leigh IM,Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290300.
  • 26
    Kanitakis J,Alhaj-Ibrahim L,Euvrard S,Claudy A. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003; 139: 11337.
  • 27
    Naldi L,Fortina AB,Lovati S,Barba A,Gotti E,Tessari G,Schena D,Diociaiuti A,Nanni G,La Parola IL,Masini C,Piaserico S,Peserico A,Cainelli T,Remuzzi G. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 14791484.
  • 28
    Lindelöf B,Granath F,Dal H,Brandberg Y,Adamai J,Ullén H. Sun habits in kidney transplant recipients with skin cancer: a case-control study of possible causative factors. Acta Derm Venereol 2003; 83: 18993.
  • 29
    Armstrong BK,Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B: Biol 2001; 63: 818.
  • 30
    English DR,Armstrong BK,Kricker A,Winter MG,Heenan PJ,Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 1998; 77: 34753.
  • 31
    Bouwes-Bavinck JN,Euvrard S,Naldi L,Nindl I,Proby CM,Neale R,Abeni D,Tessari GP,Feltkamp MCW,Claudy A,Stockfleth E. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127: 164756.
  • 32
    Carrière P,Baade P,Newman B,Aitken J,Janda M. Cancer screening in Queensland men. Med J Aust 2007; 186: 4047.
  • 33
    Martin RA,Weinstock MA,Risica PM,Smith K,Rakowski W. Factors associated with thorough skin self-examination for the early detection of melanoma. J Eur Acad Dermatol Venereol 2007; 21: 107481.
  • 34
    McKeever TM,Lewis SA,Smith C,Collins J,Heatlie H,Frischer M,Hubbard R. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax 2001; 56: 75862.
  • 35
    Hughes AM,Crouch S,Lightfoot T,Ansell P,Simpson J,Roman E. Eczema, Birth Order, and Infection. Am J Epidemiol 2008; 167: 11827.
  • 36
    Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 125960.
  • 37
    Forslund O,Iftner T,Andersson K,Lindelof B,Hradil E,Nordin P,Stenquist B,Kirnbauer R,Dillner J,de Villiers EM; Viraskin Study Group. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 87683.
  • 38
    Viviano E,Giovannelli L,Martorana E,Migliore MC,Romano N. Human papillomavirus is commonly present in psoriatic skin and normal skin samples from healthy subjects. J Dermatol Sci 2007; 45: 1413.
  • 39
    Weissenborn SJ,Nindl I,Purdie K,Harwood C,Proby C,Breuer J,Majewski S,Pfister H,Wieland U. Human papillomavirus-dna loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125: 937.
  • 40
    Yabe Y,Sakai A,Hitsumoto T,Hanafusa H,Jitsumori Y,Ogura H. Human papillomavirus-5b DNA integrated in a metastatic tumor: cloning, nucleotide sequence and genomic organization. Int J Cancer 1999; 80: 3345.
  • 41
    Jackson S,Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000; 19: 5928.
  • 42
    Rollison DE,Pawlita M,Giuliano AR,Iannacone MR,Sondak VK,Messina JL,Cruse CW,Fenske NA,Glass LF,Kienstra M,Michael KM,Waterboer T, et al. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer 2008; 123: 233742.